Galapagos NV
GLPG
#5029
Rank
A$2.64 B
Marketcap
A$39.43
Share price
0.00%
Change (1 day)
-22.17%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): A-$0.84

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is A-$0.58. In 2025 the company made an earnings per share (EPS) of A$8.13 an increase over its 2024 EPS that were of A$1.66.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.84-110.32%
2025A$8.13390.86%
2024A$1.66-67.16%
2023A$5.05-199.64%
2022A-$5.0699.03%
2021A-$2.54-68.98%
2020A-$8.20-298.06%
2019A$4.14-554.64%
2018A-$0.91-77.18%
2017A-$3.99-326.21%
2016A$1.76-134.19%
2015A-$5.16-371.34%
2014A$1.90-445.98%
2013A-$0.5532.88%
2012A-$0.41-82.07%
2011A-$2.31-817.9%
2010A$0.3212.73%
2009A$0.29-120.79%
2008A-$1.37-37.67%
2007A-$2.2039.64%
2006A-$1.5828.17%
2005A-$1.236.25%
2004A-$1.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.42-2,243.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$4.43-865.44%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$5.08-976.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.71-567.13%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$1.80-410.66%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$9.50-1,739.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$4.55-884.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
A$5.67-1,079.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$0.90-254.65%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel